JP2014528699A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014528699A5 JP2014528699A5 JP2014521612A JP2014521612A JP2014528699A5 JP 2014528699 A5 JP2014528699 A5 JP 2014528699A5 JP 2014521612 A JP2014521612 A JP 2014521612A JP 2014521612 A JP2014521612 A JP 2014521612A JP 2014528699 A5 JP2014528699 A5 JP 2014528699A5
- Authority
- JP
- Japan
- Prior art keywords
- felv
- composition
- seq
- polypeptide
- amino acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161509912P | 2011-07-20 | 2011-07-20 | |
| US61/509,912 | 2011-07-20 | ||
| PCT/US2012/023658 WO2013012446A1 (en) | 2011-07-20 | 2012-02-02 | Recombinant feline leukemia virus vaccine containing optimized feline leukemia virus envelope gene |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016212839A Division JP6240294B2 (ja) | 2011-07-20 | 2016-10-31 | 最適化ネコ白血病ウイルスエンベロープ遺伝子を含む組換えネコ白血病ウイルスワクチン |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014528699A JP2014528699A (ja) | 2014-10-30 |
| JP2014528699A5 true JP2014528699A5 (enExample) | 2015-01-08 |
| JP6084970B2 JP6084970B2 (ja) | 2017-02-22 |
Family
ID=45722710
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014521612A Active JP6084970B2 (ja) | 2011-07-20 | 2012-02-02 | 最適化ネコ白血病ウイルスエンベロープ遺伝子を含む組換えネコ白血病ウイルスワクチン |
| JP2016212839A Active JP6240294B2 (ja) | 2011-07-20 | 2016-10-31 | 最適化ネコ白血病ウイルスエンベロープ遺伝子を含む組換えネコ白血病ウイルスワクチン |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016212839A Active JP6240294B2 (ja) | 2011-07-20 | 2016-10-31 | 最適化ネコ白血病ウイルスエンベロープ遺伝子を含む組換えネコ白血病ウイルスワクチン |
Country Status (25)
| Country | Link |
|---|---|
| US (2) | US8895027B2 (enExample) |
| EP (1) | EP2734230B1 (enExample) |
| JP (2) | JP6084970B2 (enExample) |
| CN (1) | CN103957932B (enExample) |
| AU (2) | AU2012284558B2 (enExample) |
| BR (1) | BR112014001287B1 (enExample) |
| CA (1) | CA2842055C (enExample) |
| CY (1) | CY1125328T1 (enExample) |
| DK (1) | DK2734230T3 (enExample) |
| ES (1) | ES2720150T3 (enExample) |
| HR (1) | HRP20190271T1 (enExample) |
| HU (1) | HUE043547T2 (enExample) |
| IL (1) | IL230460B (enExample) |
| IN (1) | IN2014CN00547A (enExample) |
| LT (1) | LT2734230T (enExample) |
| MX (1) | MX351642B (enExample) |
| PL (1) | PL2734230T3 (enExample) |
| PT (1) | PT2734230T (enExample) |
| RS (1) | RS58289B1 (enExample) |
| RU (1) | RU2591817C2 (enExample) |
| SI (1) | SI2734230T1 (enExample) |
| SM (1) | SMT201900129T1 (enExample) |
| TR (1) | TR201901466T4 (enExample) |
| WO (1) | WO2013012446A1 (enExample) |
| ZA (1) | ZA201400349B (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2016073410A1 (en) | 2014-11-03 | 2016-05-12 | Merial, Inc. | Methods of using microneedle vaccine formulations to elicit in animals protective immunity against rabies virus |
| WO2019068905A2 (en) * | 2017-10-06 | 2019-04-11 | Virbac | Feline vaccines conferring early protection |
| EP3706789A1 (en) * | 2017-11-06 | 2020-09-16 | Intervet International B.V. | Feline calicivirus vaccine |
| CN111848785B (zh) * | 2020-07-10 | 2022-09-06 | 青岛博隆基因工程有限公司 | 猫疱疹病毒抗体序列、四肽链分子、免疫球蛋白分子 |
Family Cites Families (49)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2909462A (en) | 1955-12-08 | 1959-10-20 | Bristol Myers Co | Acrylic acid polymer laxative compositions |
| US5110587A (en) | 1981-12-24 | 1992-05-05 | Health Research, Incorporated | Immunogenic composition comprising synthetically modified vaccinia virus |
| US5505941A (en) | 1981-12-24 | 1996-04-09 | Health Research, Inc. | Recombinant avipox virus and method to induce an immune response |
| US4722848A (en) | 1982-12-08 | 1988-02-02 | Health Research, Incorporated | Method for immunizing animals with synthetically modified vaccinia virus |
| US5174993A (en) | 1981-12-24 | 1992-12-29 | Health Research Inc. | Recombinant avipox virus and immunological use thereof |
| US4603112A (en) | 1981-12-24 | 1986-07-29 | Health Research, Incorporated | Modified vaccinia virus |
| US4769330A (en) | 1981-12-24 | 1988-09-06 | Health Research, Incorporated | Modified vaccinia virus and methods for making and using the same |
| US5338683A (en) | 1981-12-24 | 1994-08-16 | Health Research Incorporated | Vaccinia virus containing DNA sequences encoding herpesvirus glycoproteins |
| US4745051A (en) | 1983-05-27 | 1988-05-17 | The Texas A&M University System | Method for producing a recombinant baculovirus expression vector |
| DE3584341D1 (de) | 1984-08-24 | 1991-11-14 | Upjohn Co | Rekombinante dna-verbindungen und expression von polypeptiden wie tpa. |
| US5168062A (en) | 1985-01-30 | 1992-12-01 | University Of Iowa Research Foundation | Transfer vectors and microorganisms containing human cytomegalovirus immediate-early promoter-regulatory DNA sequence |
| US4963481A (en) | 1985-12-18 | 1990-10-16 | Genetics Institute Inc | Promoter system |
| US4968615A (en) | 1985-12-18 | 1990-11-06 | Ciba-Geigy Corporation | Deoxyribonucleic acid segment from a virus |
| GB2197321B (en) | 1986-09-12 | 1990-10-03 | Genentech Inc | Method and vectors for obtaining continuous production of heterologous protein in a eukaryotic host cell line |
| IL84154A0 (en) | 1986-10-16 | 1988-03-31 | Microgenesys Inc | Polypeptides derived from the envelope gene of human immunodeficiency virus in recombinant baculovirus infected insect cells and vaccines against acquired immune deficiency syndrome containing the same |
| GB8717430D0 (en) | 1987-07-23 | 1987-08-26 | Celltech Ltd | Recombinant dna product |
| DE3743138A1 (de) | 1987-12-18 | 1989-09-14 | Mayr Christian Gmbh & Co Kg | Schleifringlose, elektromagnetische ueberlastkupplung |
| CA2003300A1 (en) | 1988-11-21 | 1990-05-21 | Franklin Volvovitz | Skin test and test kit for aids |
| DE68929419T2 (de) * | 1988-12-13 | 2003-04-03 | Colorado State University Research Foundation, Fort Collins | Prototypische FeLV-Isolate für die Verwendung als Krankheitsmuster oder Impfstoff |
| WO1992015672A1 (en) | 1991-03-07 | 1992-09-17 | Virogenetics Corporation | Genetically engineered vaccine strain |
| US5843456A (en) | 1991-03-07 | 1998-12-01 | Virogenetics Corporation | Alvac poxvirus-rabies compositions and combination compositions and uses |
| US6133028A (en) | 1993-05-28 | 2000-10-17 | Transgene S.A. | Defective adenoviruses and corresponding complementation lines |
| FR2712603B1 (fr) | 1993-11-18 | 1996-02-09 | Centre Nat Rech Scient | Virus recombinants, préparation et utilisation en thérapie génique. |
| US5529780A (en) | 1994-03-30 | 1996-06-25 | Virogenetics Corporation | Nucleotide and amino acid sequences of canine herpesvirus gB and gC |
| EP0826063A1 (en) | 1995-04-25 | 1998-03-04 | Vical Incorporated | Single-vial formulations of dna/lipid complexes |
| EP0803573A1 (en) | 1996-04-25 | 1997-10-29 | Gesellschaft für Biotechnologische Forschung mbH (GBF) | Polycistronic expression construct with cytokines for multivalent vaccines |
| US5846946A (en) | 1996-06-14 | 1998-12-08 | Pasteur Merieux Serums Et Vaccins | Compositions and methods for administering Borrelia DNA |
| US6156567A (en) | 1996-07-03 | 2000-12-05 | Merial | Truncated transcriptionally active cytomegalovirus promoters |
| JP2002512501A (ja) | 1996-07-03 | 2002-04-23 | メリアル インコーポレイテッド | 外来性ｄｎａを含む組換えイヌアデノウィルス（ｃａｖ） |
| US6090393A (en) | 1996-07-03 | 2000-07-18 | Merial | Recombinant canine adenoviruses, method for making and uses thereof |
| FR2775601B1 (fr) | 1998-03-03 | 2001-09-21 | Merial Sas | Vaccins vivants recombines et adjuves |
| FR2776928B1 (fr) | 1998-04-03 | 2000-06-23 | Merial Sas | Vaccins adn adjuves |
| TWI224107B (en) | 1998-10-22 | 2004-11-21 | Pfizer Prod Inc | Novel proteins from actinobacillus pleuropneumoniae |
| US6017537A (en) | 1998-12-18 | 2000-01-25 | Connaught Laboratories, Inc. | Formyl methionyl peptide vaccine adjuvant |
| US6645740B1 (en) | 1999-06-10 | 2003-11-11 | Merial Limited | Nucleic acids encodings equine GM-CSF |
| FR2796397B1 (fr) | 1999-07-16 | 2006-09-01 | Merial Sas | Genes de calicivirus felin et vaccins notamment vaccins recombines |
| IL148843A0 (en) | 1999-09-25 | 2002-09-12 | Univ Iowa Res Found | Immunostimulatory nucleic acids |
| US6852705B2 (en) | 2000-01-21 | 2005-02-08 | Merial | DNA vaccines for farm animals, in particular bovines and porcines |
| EP1203819A3 (en) | 2000-10-06 | 2002-08-07 | Transgene S.A. | Anti-inflammatory vectors |
| JP2005500336A (ja) * | 2001-07-25 | 2005-01-06 | ニューヨーク・ユニバーシティ | 感染および癌に対するワクチンのためのアジュバントとしてのグリコシルセラミドの使用 |
| FR2829498B1 (fr) | 2001-09-11 | 2003-11-28 | Merial Sas | Igf-1 comme adjuvant de vaccin felin, notamment contre les retrovirus felins |
| AU2002365202A1 (en) | 2001-11-09 | 2003-09-02 | Entremed, Inc. | Synthetic genes for malarial proteins and methods of use |
| AU2003245416A1 (en) | 2002-06-07 | 2004-04-30 | University Of Florida | Endodontic files made using bulk metallic glasses |
| ES2270120T3 (es) * | 2002-09-23 | 2007-04-01 | Mologen Ag | Vacuna contra infecciones causadas por oncovirus tales como el virus de la leucemia felina. |
| ES2347445T3 (es) * | 2004-03-30 | 2010-10-29 | Institut Gustave Roussy | Secuencia polipeptidica implicada en la modulacion del efecto inmunosupresor de las proteinas viricas. |
| SI1765387T1 (sl) | 2004-06-04 | 2013-04-30 | Merial Limited | Dajanje cepiv proti FeLV brez igle |
| US7998733B2 (en) * | 2004-10-05 | 2011-08-16 | Merial Limited | Chimeric vectors |
| ATE523207T1 (de) * | 2005-09-16 | 2011-09-15 | Merial Ltd | Stabilisatoren für gefriergetrocknete impfstoffe |
| KR20100038323A (ko) * | 2007-05-30 | 2010-04-14 | 와이어쓰 엘엘씨 | 고양이 항원의 유전자를 발현하는 라쿤 폭스바이러스 |
-
2012
- 2012-02-02 BR BR112014001287-3A patent/BR112014001287B1/pt active IP Right Grant
- 2012-02-02 MX MX2014000625A patent/MX351642B/es active IP Right Grant
- 2012-02-02 ES ES12705199T patent/ES2720150T3/es active Active
- 2012-02-02 DK DK12705199.3T patent/DK2734230T3/en active
- 2012-02-02 PT PT12705199T patent/PT2734230T/pt unknown
- 2012-02-02 WO PCT/US2012/023658 patent/WO2013012446A1/en not_active Ceased
- 2012-02-02 AU AU2012284558A patent/AU2012284558B2/en active Active
- 2012-02-02 RS RS20190039A patent/RS58289B1/sr unknown
- 2012-02-02 JP JP2014521612A patent/JP6084970B2/ja active Active
- 2012-02-02 US US13/364,993 patent/US8895027B2/en active Active
- 2012-02-02 SI SI201231522T patent/SI2734230T1/sl unknown
- 2012-02-02 HU HUE12705199A patent/HUE043547T2/hu unknown
- 2012-02-02 RU RU2014106295/15A patent/RU2591817C2/ru active
- 2012-02-02 IN IN547CHN2014 patent/IN2014CN00547A/en unknown
- 2012-02-02 CN CN201280041551.1A patent/CN103957932B/zh active Active
- 2012-02-02 EP EP12705199.3A patent/EP2734230B1/en active Active
- 2012-02-02 HR HRP20190271TT patent/HRP20190271T1/hr unknown
- 2012-02-02 LT LTEP12705199.3T patent/LT2734230T/lt unknown
- 2012-02-02 TR TR2019/01466T patent/TR201901466T4/tr unknown
- 2012-02-02 CA CA2842055A patent/CA2842055C/en active Active
- 2012-02-02 PL PL12705199T patent/PL2734230T3/pl unknown
- 2012-02-02 SM SM20190129T patent/SMT201900129T1/it unknown
-
2014
- 2014-01-14 IL IL230460A patent/IL230460B/en active IP Right Grant
- 2014-01-16 ZA ZA2014/00349A patent/ZA201400349B/en unknown
- 2014-10-06 US US14/507,455 patent/US9856295B2/en active Active
-
2016
- 2016-10-31 JP JP2016212839A patent/JP6240294B2/ja active Active
-
2017
- 2017-06-26 AU AU2017204298A patent/AU2017204298A1/en not_active Abandoned
-
2019
- 2019-02-14 CY CY20191100209T patent/CY1125328T1/el unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA202192570A1 (ru) | Иммуногенные композиции и вакцины, содержащие пептиды и белки вируса африканской чумы свиней, и их применение | |
| HRP20211566T1 (hr) | Antigeni, vektori, pripravci virusa humane imunodeficijencije i postupci njihove uporabe | |
| JP2015096070A5 (enExample) | ||
| MX2020003176A (es) | Variantes de capsides de virus adenoasociados y metodos de uso de estas. | |
| JP2008529558A5 (enExample) | ||
| RU2015155821A (ru) | Вакцины против малярии | |
| JP2013507907A5 (enExample) | ||
| EA201990718A1 (ru) | Векторы аденовируса собачьих | |
| JP2015501840A5 (enExample) | ||
| IL288541B (en) | Vaccine against rsv | |
| FI3872085T3 (fi) | Esimuotoiset virussekvenssit ja niiden käytöt | |
| HRP20130022T1 (hr) | Fuzijski proteini koji sadrže antigene ny-eso-1 i lage-1 za odbacivanje tumora | |
| RU2014135053A (ru) | Иммуногены для вакцинации против вич | |
| JP2016222689A5 (ja) | 合成ペプチド及び乾燥粉末薬剤輸送システム | |
| JP2015186478A5 (enExample) | ||
| JP2008056679A5 (enExample) | ||
| JP2009544333A5 (enExample) | ||
| MX2021015465A (es) | Vacuna para fiebre porcina africana. | |
| EA202090738A1 (ru) | Способ безопасного индуцирования иммунитета против rsv | |
| EA201591213A1 (ru) | Вакцины против вируса гепатита b | |
| JP2014529399A5 (enExample) | ||
| JP2016520534A5 (enExample) | ||
| RU2021109510A (ru) | Вакцинация с использованием альфа 3 домена mica/b для лечения рака | |
| WO2016116905A9 (en) | Cmv antigens and uses thereof | |
| JP2018501258A5 (enExample) |